0000950170-24-059787.txt : 20240514 0000950170-24-059787.hdr.sgml : 20240514 20240514171613 ACCESSION NUMBER: 0000950170-24-059787 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240510 FILED AS OF DATE: 20240514 DATE AS OF CHANGE: 20240514 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lemaitre Dan CENTRAL INDEX KEY: 0001478479 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35621 FILM NUMBER: 24945731 MAIL ADDRESS: STREET 1: 2 MUSICK CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GLOBUS MEDICAL INC CENTRAL INDEX KEY: 0001237831 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 043744954 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 BUSINESS PHONE: 610-930-1800 MAIL ADDRESS: STREET 1: 2560 GENERAL ARMISTEAD AVENUE CITY: AUDUBON STATE: PA ZIP: 19403 4 1 ownership.xml 4 X0508 4 2024-05-10 0001237831 GLOBUS MEDICAL INC GMED 0001478479 Lemaitre Dan VALLEY FORGE BUSINESS CENTER 2560 GENERAL ARMISTEAD AVENUE AUDUBON PA 19403 true false false false false Class A Common Stock 2024-05-10 4 M false 17500 43.77 A 28300 D Class A Common Stock 2024-05-10 4 M false 17500 43.58 A 45800 D Class A Common Stock 2024-05-10 4 M false 17500 53.27 A 63300 D Class A Common Stock 2024-05-10 4 S false 63300 64.6133 D 0 D Stock Option (Right to Buy Class A Common Stock) 43.77 2024-05-10 4 M false 17500 0 D 2028-01-22 Class A Common Stock 17500 0 D Stock Option (Right to Buy Class A Common Stock) 43.58 2024-05-10 4 M false 17500 0 D 2029-01-22 Class A Common Stock 17500 0 D Stock Option (Right to Buy Class A Common Stock) 53.27 2024-05-10 4 M false 17500 0 D 2030-01-22 Class A Common Stock 17500 0 D The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.80 to $64.68, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4. These options were granted on January 22, 2018 and are fully vested. These options were granted on January 22, 2019 and are fully vested. These options were granted on January 22, 2020 and are fully vested. /s/ Kelly G. Huller, Attorney-in-Fact 2024-05-14